Moving beyond cytotoxic drug dosing in ovarian cancer

Journal article

Open access

Peer reviewed

Ramez N Eskander and Bradley J Monk

The Lancet (British edition), Vol.394(10214), pp.2043-2045

12/07/2019

PMID: 31791687

Abstract

Animals

Antineoplastic Agents

Carcinoma

Fallopian Tubes

Female

Humans

Ovarian Neoplasms

Progression-Free Survival

url

https://doi.org/10.1016/S0140-6736(19)32948-4View

Published (Version of record) Open

1 Record Views

Title: Moving beyond cytotoxic drug dosing in ovarian cancer
Creators: Ramez N Eskander - University of California, San Diego
Bradley J Monk - University of California, San Diego
Publication Details: The Lancet (British edition), Vol.394(10214), pp.2043-2045
Identifiers: 991005969045902656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article